stage iv renal cell cancer

Showing 1 - 25 of 61

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer Trial in New Brunswick (Arterial Spin

Completed
  • Stage I Renal Cell Cancer
  • +3 more
  • Arterial Spin Labeling Magnetic Resonance Imaging
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Oct 14, 2022

Advanced Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Seattle (Aldesleukin,

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • Pembrolizumab
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 5, 2022

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester

Terminated
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Buffalo, New York
  • +1 more
Aug 11, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Anti-OX40 Antibody PF-04518600
  • +3 more
  • Los Angeles, California
  • +9 more
Aug 5, 2022

Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Buffalo (radiation, procedure, other)

Completed
  • Recurrent Renal Cell Cancer
  • Stage IV Renal Cell Cancer
  • stereotactic body radiation therapy
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Diarrhea, Metastatic Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Duarte (other, dietary supplement, drug)

Active, not recruiting
  • Diarrhea
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jun 7, 2022

Metastatic Renal Cell Cancer, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Chicago (Stereotactic Body

Recruiting
  • Metastatic Renal Cell Cancer
  • +2 more
  • Stereotactic Body Radiation Therapy
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jun 3, 2022

Metastatic Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Sacramento (Ibrutinib, Nivolumab)

Completed
  • Metastatic Renal Cell Cancer
  • Stage IV Renal Cell Cancer
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Feb 8, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma

Active, not recruiting
  • Recurrent Malignant Solid Neoplasm
  • +15 more
  • Canady Helios Cold Plasma Scalpel
  • Washington, District of Columbia
    Canady Surgical Group PC
Jul 16, 2021

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Los Angeles

Completed
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • AdGMCAIX-transduced autologous dendritic cells
  • +2 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Jul 28, 2021

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +44 more
  • fludarabine phosphate
  • +9 more
  • Duarte, California
  • +6 more
Sep 6, 2019

Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (drug, radiation, procedure, biological, other)

Completed
  • Recurrent Renal Cell Cancer
  • Stage IV Renal Cell Cancer
  • fludarabine phosphate
  • +7 more
  • Tucson, Arizona
  • +5 more
Jul 23, 2019

Magnetic Resonance Imaging in Predicting Response to Sunitinib

Completed
  • Renal Cell Carcinoma
  • +2 more
  • mutation analysis
  • +5 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Jun 21, 2019

Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory

Completed
  • Advanced Malignant Neoplasm
  • +31 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Jun 5, 2019

Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in United States (Erlotinib

Completed
  • Recurrent Renal Cell Carcinoma
  • +4 more
  • Erlotinib Hydrochloride
  • +2 more
  • Tucson, Arizona
  • +213 more
Dec 12, 2018

B-Cell Tumor, Estrogen Receptor Negative, HER2/Neu Negative Trial in Stanford (18F-FSPG, 18F-FDG)

Completed
  • B-Cell Neoplasm
  • +15 more
  • Stanford, California
    Stanford University Medical Center
Dec 11, 2018

Fatigue, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Cleveland (procedure, other, drug)

Terminated
  • Fatigue
  • +2 more
  • transcranial magnetic stimulation
  • +3 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Nov 14, 2018

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer Trial in Houston (procedure, drug,

Terminated
  • Clear Cell Renal Cell Carcinoma
  • +2 more
  • therapeutic conventional surgery
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 22, 2018

Stage IV Renal Cell Cancer Trial in Berlin, Bonn, Hannover (MGN1601)

Completed
  • Stage IV Renal Cell Cancer
  • MGN1601
  • Berlin, Germany
  • +2 more
Nov 13, 2018

Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Cleveland (sunitinib malate)

Completed
  • Clear Cell Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer
  • sunitinib malate
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 17, 2018

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Australia, Taiwan, United

Completed
  • Clear Cell Renal Cell Carcinoma
  • +4 more
  • Anti-Endoglin Chimeric Monoclonal Antibody TRC105
  • +3 more
  • Duarte, California
  • +29 more
Jul 30, 2018

Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected

Completed
  • Recurrent Melanoma
  • +11 more
  • siRNA-transfected peripheral blood mononuclear cells APN401
  • laboratory biomarker analysis
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jul 2, 2018